Cargando…

Apelin and Atrial Fibrillation: The Role in the Arrhythmia Recurrence Prognosis

Apelin is a novel peptide of wide expression and multiple biological functions including the crucial role in cardiovascular homeostasis. The apelin role in the pathophysiology of heart rhythm disorders is considered, although the reports are scarce so far. The purpose of this study is to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Salska, Agata, Dziuba, Michał, Salski, Witold, Chizynski, Krzysztof, Zielinska, Marzenna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867588/
https://www.ncbi.nlm.nih.gov/pubmed/29721104
http://dx.doi.org/10.1155/2018/5285392
_version_ 1783308993652850688
author Salska, Agata
Dziuba, Michał
Salski, Witold
Chizynski, Krzysztof
Zielinska, Marzenna
author_facet Salska, Agata
Dziuba, Michał
Salski, Witold
Chizynski, Krzysztof
Zielinska, Marzenna
author_sort Salska, Agata
collection PubMed
description Apelin is a novel peptide of wide expression and multiple biological functions including the crucial role in cardiovascular homeostasis. The apelin role in the pathophysiology of heart rhythm disorders is considered, although the reports are scarce so far. The purpose of this study is to investigate the potential utility of apelin as a marker of arrhythmia recurrence after direct-current cardioversion (DC). The prospective, observational study included 60 patients (aged 41–86; 30% female) with nonvalvular, persistent atrial fibrillation from the group of 204 consecutive patients scheduled for DC during the 12-month period (from May 2010 to May 2011) in the Cardiology Clinic Medical University of Lodz, Poland. The study group was divided into SCD (successful DC), 45 (75%) patients, and NDC (nonsuccessful DC), 15 (25%) patients. Within the SCD group, the subgroups were distinguished depending on the time sinus rhythm maintenance after DC: up to 7 days (SDC-7), 11 patients; 7 to 30 days (SDC-30), 12 patients; over 90 days (SDC-90), 22 patients. Patients were evaluated during the hospitalization and within the 3-month follow-up period. The apelin level was determined within the plasma samples collected at the admission, using the commercially available enzyme-linked immunosorbent assay (ELISA) Kit for apelin-36. It was found that the median value of initial apelin in the subset of patients from groups NDC + SDC-7 + SDC-30 is significantly higher than from group SDC-90 (p = 0.0463); there was no relationship between NDC and SCD overall. Neither of the compared subgroup pairs revealed statistically significant correlation between the proBNP concentration and the DC effectiveness in our population. In conclusion, in our study, proBNP was not a marker of arrhythmia recurrence whereas higher apelin concentration at the admission indicated patients in whom DC was not effective or they had an arrhythmia recurrence within a month-period observation.
format Online
Article
Text
id pubmed-5867588
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-58675882018-05-02 Apelin and Atrial Fibrillation: The Role in the Arrhythmia Recurrence Prognosis Salska, Agata Dziuba, Michał Salski, Witold Chizynski, Krzysztof Zielinska, Marzenna Dis Markers Research Article Apelin is a novel peptide of wide expression and multiple biological functions including the crucial role in cardiovascular homeostasis. The apelin role in the pathophysiology of heart rhythm disorders is considered, although the reports are scarce so far. The purpose of this study is to investigate the potential utility of apelin as a marker of arrhythmia recurrence after direct-current cardioversion (DC). The prospective, observational study included 60 patients (aged 41–86; 30% female) with nonvalvular, persistent atrial fibrillation from the group of 204 consecutive patients scheduled for DC during the 12-month period (from May 2010 to May 2011) in the Cardiology Clinic Medical University of Lodz, Poland. The study group was divided into SCD (successful DC), 45 (75%) patients, and NDC (nonsuccessful DC), 15 (25%) patients. Within the SCD group, the subgroups were distinguished depending on the time sinus rhythm maintenance after DC: up to 7 days (SDC-7), 11 patients; 7 to 30 days (SDC-30), 12 patients; over 90 days (SDC-90), 22 patients. Patients were evaluated during the hospitalization and within the 3-month follow-up period. The apelin level was determined within the plasma samples collected at the admission, using the commercially available enzyme-linked immunosorbent assay (ELISA) Kit for apelin-36. It was found that the median value of initial apelin in the subset of patients from groups NDC + SDC-7 + SDC-30 is significantly higher than from group SDC-90 (p = 0.0463); there was no relationship between NDC and SCD overall. Neither of the compared subgroup pairs revealed statistically significant correlation between the proBNP concentration and the DC effectiveness in our population. In conclusion, in our study, proBNP was not a marker of arrhythmia recurrence whereas higher apelin concentration at the admission indicated patients in whom DC was not effective or they had an arrhythmia recurrence within a month-period observation. Hindawi 2018-03-12 /pmc/articles/PMC5867588/ /pubmed/29721104 http://dx.doi.org/10.1155/2018/5285392 Text en Copyright © 2018 Agata Salska et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Salska, Agata
Dziuba, Michał
Salski, Witold
Chizynski, Krzysztof
Zielinska, Marzenna
Apelin and Atrial Fibrillation: The Role in the Arrhythmia Recurrence Prognosis
title Apelin and Atrial Fibrillation: The Role in the Arrhythmia Recurrence Prognosis
title_full Apelin and Atrial Fibrillation: The Role in the Arrhythmia Recurrence Prognosis
title_fullStr Apelin and Atrial Fibrillation: The Role in the Arrhythmia Recurrence Prognosis
title_full_unstemmed Apelin and Atrial Fibrillation: The Role in the Arrhythmia Recurrence Prognosis
title_short Apelin and Atrial Fibrillation: The Role in the Arrhythmia Recurrence Prognosis
title_sort apelin and atrial fibrillation: the role in the arrhythmia recurrence prognosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867588/
https://www.ncbi.nlm.nih.gov/pubmed/29721104
http://dx.doi.org/10.1155/2018/5285392
work_keys_str_mv AT salskaagata apelinandatrialfibrillationtheroleinthearrhythmiarecurrenceprognosis
AT dziubamichał apelinandatrialfibrillationtheroleinthearrhythmiarecurrenceprognosis
AT salskiwitold apelinandatrialfibrillationtheroleinthearrhythmiarecurrenceprognosis
AT chizynskikrzysztof apelinandatrialfibrillationtheroleinthearrhythmiarecurrenceprognosis
AT zielinskamarzenna apelinandatrialfibrillationtheroleinthearrhythmiarecurrenceprognosis